Why Is UiPath (PATH) Stock Down Premarket Today Despite an Earnings Beat?
Image courtesy of 123rf.com

Why Is UiPath (PATH) Stock Down Premarket Today Despite an Earnings Beat?

UiPath stock fell in premarket trading despite beating Q4 earnings estimates, as investors reacted cautiously to the company’s outlook for fiscal 2027.
Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions.

Shares of UiPath, Inc. (NYSE: PATH) tumbled in premarket trading on Thursday, March 12, 2026, even as the automation software company delivered a fiscal fourth quarter earnings report that surpassed Wall Street expectations on both the top and bottom lines. The sell-off reflects a recurring tension in today’s market: strong historical results are not enough if forward guidance fails to ignite investor enthusiasm.

Despite beating estimates on revenue and adjusted earnings per share, UiPath’s growth outlook for fiscal year 2027 appeared to leave investors wanting more, sending the stock sharply lower in early trading before a partial recovery later in the session.

UiPath Earnings Beat Expectations but Guidance Disappoints

For its fiscal fourth quarter ended January 31, 2026, UiPath reported adjusted earnings of $0.30 per share, meaningfully ahead of the analyst consensus estimate of $0.25. Revenue climbed 14% year-over-year to $481.1 million, also topping the Street’s estimate of approximately $464.9 million. Annual Recurring Revenue (ARR) reached $1.853 billion, up 11% year-over-year, while net new ARR for the quarter came in at $70 million.

The company also reported GAAP operating income of $80 million and non-GAAP operating income of $150 million for the quarter, and for the full fiscal year achieved GAAP profitability for the first time in company history, a milestone CFO Ashim Gupta highlighted as evidence of improving operational discipline.

Despite these headline beats, investors focused on the forward guidance, which offered little in the way of upside surprise. For Q1 FY2027, UiPath guided revenue of $395–$400 million, and for the full fiscal year it projected revenue of $1.754–$1.759 billion alongside ARR of $2.051–$2.056 billion.

While these figures represent continued growth, they were broadly in line with, rather than ahead of, market expectations, a dynamic that disappointed momentum-driven investors hoping for an acceleration in the company’s growth trajectory.

Adding to the cautious sentiment, UiPath’s dollar-based net retention rate stood at 107%, a metric that tracks expansion from existing customers and has been under pressure. The figure indicates that while customers are spending more over time, the rate of expansion is modest relative to the growth rates investors associate with high-multiple software companies.

Shares had already declined more than 24% year-to-date heading into the print, reflecting broader softness in software infrastructure names, and the guidance print did little to reverse that trend in the immediate aftermath.

Join our Telegram group and never miss a breaking digital asset story.

PATH Stock Brief: Performance, Valuation, and Analyst Outlook

UiPath shares closed at $11.59 on March 11, 2026, before falling approximately 8.81% to $11.29 in premarket trading on March 12 at 8:07 AM EDT, a sharp move that reflected the market’s initial disappointment with the guidance.

However, the stock subsequently recovered during the regular session, closing March 12 at $12.38, up $0.79 or approximately 6.82% from the prior close, suggesting that some investors viewed the premarket dip as an overreaction. Volume on the day surged to roughly 95 million shares against an average of around 32 million, underscoring the heightened activity around the earnings event.

From a valuation and trend perspective, PATH trades at a trailing price-to-earnings ratio of approximately 29.5x and a forward P/E of around 16.8x, with a market capitalization of $6.62 billion. The stock’s 52-week range of $9.38–$19.84 illustrates the significant volatility the name has experienced, and its performance relative to the broader market has been a persistent challenge — PATH is down roughly 24.5% year-to-date compared to a modest decline of about 1% for the S&P 500 over the same period.

On a five-year basis, the stock has lost over 81% of its value against the S&P 500’s roughly 72% gain, a stark reminder of the multiple compression that has hit high-growth software names since their 2021 peak.

Analyst sentiment remains cautiously constructive. The consensus analyst price target stands at approximately $14.99, representing meaningful upside from current levels, with the price target range running from $12.00 on the low end to $19.00 on the high end. Morgan Stanley maintained an Equal-Weight rating while lowering its price target from $19 to $17, while Canaccord Genuity’s top analyst holds a Buy rating.

UiPath also announced a new $500 million stock repurchase authorization following the completion of its prior $1 billion buyback program, a signal of management’s confidence in the stock at current levels and a potential floor for the shares going forward.

Disclaimer: The author does not hold or have a position in any securities discussed in the article. All stock prices were quoted at the time of writing.